Metabolic heterogeneity and adaptability in brain tumors

被引:44
作者
Badr, Christian E. [1 ,2 ]
Silver, Daniel J. [3 ,4 ]
Siebzehnrubl, Florian A. [5 ]
Deleyrolle, Loic P. [6 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[2] Harvard Med Sch, Neurosci Program, Boston, MA 02115 USA
[3] Cleveland Clin Fdn, Dept Cardiovasc & Metab Sci, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[4] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
[5] Cardiff Univ, European Canc Stem Cell Res Inst, Sch Biosci, Cardiff CF24 4HQ, Wales
[6] Univ Florida, Lillian S Wells Dept Neurosurg, Preston A Wells Jr Ctr Brain Tumor Therapy, Gainesville, FL 32611 USA
关键词
Glioma; Tumor microenvironment (TME); Metabolism; Cell communication; Tumor initiating cells; Slow-cycling cells; Immune cells; FATTY-ACID OXIDATION; CANCER STEM-CELLS; GLUCOSE-TRANSPORTER GLUT1; HUMAN GLIOBLASTOMA; SUPPRESSOR-CELLS; INITIATING CELLS; DENDRITIC CELLS; SELF-RENEWAL; INTRATUMOR HETEROGENEITY; SYNTHETIC LETHALITY;
D O I
10.1007/s00018-020-03569-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The metabolic complexity and flexibility commonly observed in brain tumors, especially glioblastoma, is fundamental for their development and progression. The ability of tumor cells to modify their genetic landscape and adapt metabolically, subverts therapeutic efficacy, and inevitably instigates therapeutic resistance. To overcome these challenges and develop effective therapeutic strategies targeting essential metabolic processes, it is necessary to identify the mechanisms underlying heterogeneity and define metabolic preferences and liabilities of malignant cells. In this review, we will discuss metabolic diversity in brain cancer and highlight the role of cancer stem cells in regulating metabolic heterogeneity. We will also highlight potential therapeutic modalities targeting metabolic vulnerabilities and examine how intercellular metabolic signaling can shape the tumor microenvironment.
引用
收藏
页码:5101 / 5119
页数:19
相关论文
共 198 条
  • [1] Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism
    Achreja, Abhinav
    Zhao, Hongyun
    Yang, Lifeng
    Yun, Tae Hyun
    Marini, Juan
    Nagrath, Deepak
    [J]. METABOLIC ENGINEERING, 2017, 43 : 156 - 172
  • [2] Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
    Agnihotri, Sameer
    Zadeh, Gelareh
    [J]. NEURO-ONCOLOGY, 2016, 18 (02) : 160 - 172
  • [3] TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
    Anido, Judit
    Saez-Borderias, Andrea
    Gonzalez-Junca, Alba
    Rodon, Laura
    Folch, Gerard
    Carmona, Maria A.
    Prieto-Sanchez, Rosa M.
    Barba, Ignasi
    Martinez-Saez, Elena
    Prudkin, Ludmila
    Cuartas, Isabel
    Raventos, Carolina
    Martinez-Ricarte, Francisco
    Antonia Poca, M.
    Garcia-Dorado, David
    Lahn, Michael M.
    Yingling, Jonathan M.
    Rodon, Jordi
    Sahuquillo, Juan
    Baselga, Jose
    Seoane, Joan
    [J]. CANCER CELL, 2010, 18 (06) : 655 - 668
  • [4] Harnessing dendritic cells in cancer
    Apetoh, Lionel
    Locher, Clara
    Ghiringhelli, Francois
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. SEMINARS IN IMMUNOLOGY, 2011, 23 (01) : 42 - 49
  • [5] A Metabolic Shift toward Pentose Phosphate Pathway Is Necessary for Amyloid Fibril-and Phorbol 12-Myristate 13-Acetate-induced Neutrophil Extracellular Trap (NET) Formation
    Azevedo, Estefania P.
    Rochael, Natalia C.
    Guimaraes-Costa, Anderson B.
    de Souza-Vieira, Thiago S.
    Ganilho, Juliana
    Saraiva, Elvira M.
    Palhano, Fernando L.
    Foguel, Debora
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (36) : 22174 - 22183
  • [6] Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas
    Azzalin, Alberto
    Nato, Giulia
    Parmigiani, Elena
    Garello, Francesca
    Buffo, Annalisa
    Magrassi, Lorenzo
    [J]. NEOPLASIA, 2017, 19 (04): : 364 - 373
  • [7] Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
    Bao, Shideng
    Wu, Qiulian
    McLendon, Roger E.
    Hao, Yueling
    Shi, Qing
    Hjelmeland, Anita B.
    Dewhirst, Mark W.
    Bigner, Darell D.
    Rich, Jeremy N.
    [J]. NATURE, 2006, 444 (7120) : 756 - 760
  • [8] Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence
    Baysan, Mehmet
    Woolard, Kevin
    Cam, Margaret C.
    Zhang, Wei
    Song, Hua
    Kotliarova, Svetlana
    Balamatsias, Demosthenes
    Linkous, Amanda
    Ahn, Susie
    Walling, Jennifer
    Belova, Galina I.
    Fine, Howard A.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (10) : 2002 - 2013
  • [9] Lipid metabolic reprogramming in cancer cells
    Beloribi-Djefaflia, S.
    Vasseur, S.
    Guillaumond, F.
    [J]. ONCOGENESIS, 2016, 5 : e189 - e189
  • [10] Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1α
    Ben-Shoshan, Jeremy
    Maysel-Auslender, Sophia
    Mor, Adi
    Keren, Gad
    George, Jacob
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (09) : 2412 - 2418